Solarase Approved In Canada For Precancerous Skin Lesions
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Solarase Approved In Canada For Precancerous Skin Lesions

MISSISSAUGA, ON -- May 20, 1998 -- The Therapeutic Products Directorate of Health Canada (formerly HPB) has granted marketing approval to Hyal Pharmaceutical Corp.’s Solarase™, a topical gel formulation to treat actinic keratosis (AK), precancerous skin lesions caused by exposure to the sun.

AK is a common precancerous skin lesion caused by overexposure to sunlight. A small number of these lesions will develop into squamus cell carcinoma, a malignant skin disease. According to The Skin Cancer Foundation of the United States, AK affects one in six people world-wide.

Hyal expects to file a submission to the FDA in the third quarter seeking approval to market Solarase in the U.S.

Solarase utilises Hyal's patented HIT technology which targets and retains drugs in areas of dermal pathology. The benefits to the patient are minimal systemic drug absorption and outstanding safety.

More information on: Solarase and Hyal Pharmaceutical Corp.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities